Sign in
CompletedNo phase

Transitions Clinic Network: Post Incarceration Addiction Treatment, Healthcare, and Social Support

Key facts

Who runs it
Yale University
Where
Chapel Hill, Minneapolis, New Haven, and The Bronx, United StatesSee the 4 sitesAlso in 1 other country, 1 site
Trial code
Status
Completed
People taking part
398 people enrolled
Started
21 Apr 2021
Ended
30 Dec 2025
Type of study
Interventional, 2 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • Transitions Clinic Network Primary Care
  • Standard Primary Care
Record updated
12 May 2026

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 8 criteriaShow less

Who can take part

  • 18 years or older
  • English and Spanish-speaking,
  • Meeting current DSM-5 criteria for OUD

Who cannot take part

  • women of child-bearing age will be excluded if they are pregnant
  • acutely psychotic, suicidal or homicidal,
  • require prescription opioids for acute pain, chronic pain or palliative care without OUD,
  • have a planned relocation that makes it unlikely they would be able to complete the study and follow-up assessments,
  • have a primary care provider that they already have established care with in the community,

Where in United States

Also in 1 other country, 1 site

  • UNC- Chapel HillChapel Hill, United States
  • Hennepin HealthcareMinneapolis, United States
  • YaleNew Haven, United States
  • Albert Einstein College of MedicineThe Bronx, United States

About the trial

What the trial wants to find out

TCN PATHS will recruit an anticipated 400 participants who are prescribed MOUD who are released from detention facilities. Each individual will be randomized to either 1) standard primary care (SPC) or 2) a Transitions Clinic Network (TCN) program primary care. Participants will be followed for a year and complete surveys at baseline and at month 1, 3, 6, 9, and 12. At each of these points research staff will confirm MOUD status. Urine drug screenings will be completed at baseline, month 1, 6, and 12 if the participant is not incarcerated. When possible, research staff will collect electronic health records.

The 2 groups in the trial

  • Standard Primary CareExisting treatment, for comparison

    Those randomized to the standard primary care arm will be referred to primary care and community Opioid Treatment Program (OTP). Participants may receive buprenorphine or Extended-release naltrexone (XR-NTX) through primary care or with a community addiction treatment provider.

  • Transitions Clinic Network Primary CareTreatment being tested

    Transitions Clinic Network (TCN)- participants in this arm will be referred to a TCN program for primary care and community Opioid Treatment Program (OTP). All TCN programs have the ability to prescribe buprenorphine and Extended-release naltrexone (XR-NTX) and assist with referrals to methadone. The primary features of the TCN include (1) primary care and onsite MOUD or referral to community treatment when indicated, (2) addressing social determinants of OUD and care coordination through a Community Health Worker (CHW), and (3) addressing the discrimination and stigma that exist based on incarceration.

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Publications
Record updated
12 May 2026